{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:39:11Z","timestamp":1772041151353,"version":"3.50.1"},"reference-count":25,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,6,1]]},"DOI":"10.5551\/jat.63773","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T22:11:07Z","timestamp":1661551867000},"page":"663-674","source":"Crossref","is-referenced-by-count":5,"title":["Impact of Guideline-Directed Medical Therapy on 10-Year Mortality after Revascularization for Patients with Chronic Limb-Threatening Ischemia"],"prefix":"10.5551","volume":"30","author":[{"given":"Yosuke","family":"Hata","sequence":"first","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonori","family":"Nanto","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tsujimura","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Higashino","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Toyoshima","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikurou","family":"Kitano","sequence":"additional","affiliation":[{"name":"Department of Surgery, Shinsuma General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Surgery, Shinsuma General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[{"name":"Kansai Rosai Hospital Cardiovascular Center, Inabaso"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, L\u00fcders F, Gebauer K, Roeder N, Berger K, Malyar NM. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J, 2015; 36: 932-938","DOI":"10.1093\/eurheartj\/ehv006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Shiraki T, Iida O, Takahara M, Okamoto S, Kitano I, Tsuji Y, Terashi H, Uematsu M. Predictive scoring model of mortality after surgical or endovascular revascularization in patients with critical limb ischemia. J Vasc Surg, 2014; 60: 383-389","DOI":"10.1016\/j.jvs.2014.02.059"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg, 2009; 50: 1462-1473","DOI":"10.1016\/j.jvs.2009.09.044"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) van Reijen NS, Hensing T, Santema TKB, Ubbink DT, Koelemay MJW. Outcomes of Conservative Treatment in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg, 2021; 62: 214-224","DOI":"10.1016\/j.ejvs.2021.01.005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Iida O, Takahara M, Soga Y, Azuma N, Nanto S, Uematsu M; PRIORITY Investigators. Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia). JACC Cardiovasc Interv, 2017; 10: 1147-1157","DOI":"10.1016\/j.jcin.2017.03.012"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Soga Y, Iida O, Takahara M, Hirano K, Suzuki K, Kawasaki D, Miyashita Y, Tsuchiya T. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv, 2014; 7: 1444-1449","DOI":"10.1016\/j.jcin.2014.06.018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, R\u00f6ther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 2018; 39: 763-816","DOI":"10.5603\/KP.2017.0216"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 1996; 348: 1329-1339","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg, 2007; 45: 645-654","DOI":"10.1016\/j.jvs.2006.12.054"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Armstrong EJ, Chen DC, Singh GD, Amsterdam EA, Laird JR. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vasc Med, 2015; 20: 237-244","DOI":"10.1177\/1358863X15574321"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) von Allmen RS, Weiss S, Tevaearai HT, Kuemmerli C, Tinner C, Carrel TP, Schmidli J, Dick F. Completeness of Follow-Up Determines Validity of Study Findings: Results of a Prospective Repeated Measures Cohort Study. PLoS One, 2015; 10: e0140817","DOI":"10.1371\/journal.pone.0140817"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) De Martino RR, Hoel AW, Beck AW, Eldrup-Jorgensen J, Hallett JW, Upchurch GR, Cronenwett JL, Goodney PP; Vascular Quality Initiative. Participation in the Vascular Quality Initiative is associated with improved perioperative medication use, which is associated with longer patient survival. J Vasc Surg, 2015; 61: 1010-1019","DOI":"10.1016\/j.jvs.2014.11.073"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ardati AK, Kaufman SR, Aronow HD, Nypaver TJ, Bove PG, Gurm HS, Grossman PM. The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions. Circ Cardiovasc Interv, 2012; 5: 850-855","DOI":"10.1161\/CIRCINTERVENTIONS.112.975862"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, Yeo KK, Anderson D, Amsterdam EA, Laird JR. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc, 2014; 3: e000697","DOI":"10.1161\/JAHA.113.000697"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002; 360: 7-22","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, Wilson PWF. Association of statin dose with amputation and survival in patients with peripheral artery disease. Circulation, 2018; 137: 1435-1446","DOI":"10.1161\/CIRCULATIONAHA.117.032361"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation, 2011; 124: 17-23","DOI":"10.1161\/CIRCULATIONAHA.110.003954"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hess CN, Cannon CP, Beckman JA, Goodney PP, Patel MR, Hiatt WR, Mues KE, Orroth KK, Shannon E, Bonaca MP. Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease. J Am Coll Cardiol, 2021; 77: 3016-3027","DOI":"10.1016\/j.jacc.2021.04.060"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Feringa HH, van Waning VH, Bax JJ, Elhendy A, Boersma E, Schouten O, Galal W, Vidakovic RV, Tangelder MJ, Poldermans D. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol, 2006; 47: 1182-1187","DOI":"10.1016\/j.jacc.2005.09.074"},{"key":"20","unstructured":"20) Heart Outcomes Prevention Evaluation Study Investigators, Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000; 342: 145-153"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Thomas Manapurathe D, Krishna SM, Dewdney B, Moxon JV, Biros E, Golledge J. Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials. PLoS One, 2017; 12: e0178713","DOI":"10.1371\/journal.pone.0178713"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation, 1994; 90: 2056-2069","DOI":"10.1161\/01.CIR.90.4.2056"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation, 2000; 101: 1372-1378","DOI":"10.1161\/01.CIR.101.12.1372"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Cho S, Lee YJ, Ko YG, Kang TS, Lim SH, Hong SJ, Ahn CM, Kim JS, Kim BK, Choi D, Hong MK, Jang Y. Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease. JACC Cardiovasc Interv, 2019; 12: 2359-2370","DOI":"10.1016\/j.jcin.2019.08.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Renard BM, Seth M, Share D, Aronow HD, Laveroni EW, De Gregorio M, Hans SS, Henke PK, Gurm HS, Grossman PM. If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease. Vasc Med, 2015; 20: 544-550","DOI":"10.1177\/1358863X15599249"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/6\/30_63773\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T04:33:59Z","timestamp":1685766839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/6\/30_63773\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.63773","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"article-number":"63773"}}